Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
How does Cordyceps sinensis work to improve energy?
Cordyceps sinensis improves energy by increasing the production of adenosine triphosphate (ATP), which is essential for delivering oxygen to muscles and supporting cellular energy. The active compound cordycepin is structurally similar to adenosine and appears to enhance mitochondrial function and oxygen utilization. This mechanism supports its traditional use for fatigue and stamina, though clinical evidence is currently limited (Evidence Level: C).
Does Cordyceps interact with immunosuppressant medications?
Yes, Cordyceps poses a significant interaction risk with immunosuppressants. Because the fungus stimulates immune activity through its polysaccharide content, it may counteract the effects of drugs prescribed to suppress the immune system, such as those used after organ transplants or for autoimmune diseases. Patients on immunosuppressive therapy should avoid Cordyceps to prevent potential treatment failure or disease flare-ups.
What is the recommended daily dosage for Cordyceps?
For the wild-harvested Cordyceps sinensis, the traditional dosage is 1 to 3 grams of the dried fungus daily. For standardized extracts, often derived from the cultivated Cordyceps militaris species, a common dosage is 400 mg taken twice daily. Users should verify whether they are consuming wild or cultivated forms, as potency varies, and adhere to specific product label instructions.
Is Cordyceps safe to take during pregnancy?
No, Cordyceps is considered unsafe during pregnancy and breastfeeding. There is insufficient safety data to support its use for expecting mothers, and its potential hormonal and immune-modulating effects pose theoretical risks to the fetus. Traditional medical texts also advise against its use in these populations. Women who are pregnant or nursing should avoid this supplement entirely.
What is Cordyceps used for in traditional medicine?
In Traditional Chinese Medicine (TCM) and Tibetan medicine, Cordyceps is primarily used as a tonic for kidney and lung deficiency. It is prescribed to strengthen the respiratory system, enhance sexual vitality, and aid recovery from chronic fatigue or long-term illness. Considered a precious adaptogen, it helps the body resist physical stress, though robust clinical trials are still needed to confirm these uses (Evidence Level: C).
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Cordyceps sinensis, also known as Ophiocordyceps sinensis or 'winter worm-summer grass', is a highly valued medicinal fungus used in traditional Tibetan and Chinese medicine [PMID:24716152, PMID:29371523].
Contexte
It is an entomogenous, endoparasitic fungus that parasitizes the larvae of moths (Lepidoptera) [PMID:29371523, PMID:32288794, PMID:25704018]. It is primarily found on the Tibetan Plateau and in the Himalayan region [PMID:30394122, PMID:39331691].
Usages traditionnels
Used in traditional Tibetan and Chinese medicine as a prestigious tonic and therapeutic herb [PMID:24716152, PMID:32362940]. It is traditionally used to tonify the lung and kidney [PMID:35645822, PMID:38375041] and as a tonic supplement for sexual and reproductive dysfunctions [PMID:28911537].
Composés actifs
Bioactive ingredients include polysaccharides (extracellular and intracellular), nucleosides (such as cordycepin, adenosine, guanine, guanosine, hypoxanthine, uridine, inosine, thymidine, and adenine), sterols, proteins, amino acids, polypeptides, and specific compounds like cordysinin (A-E) and epipolythiodioxopiperazines (gliocladicillins A and B) [PMID:24716152, PMID:39519748, PMID:32288794, PMID:25960753, PMID:27874103].
Mécanisme d'action
Mechanisms include immunomodulatory, anti-inflammatory, antioxidant, and anti-apoptotic activities [PMID:24716152, PMID:25960753]. Cordycepin specifically may exert anticancer effects via stimulation of the adenosine A3 receptor, leading to glycogen synthase kinase (GSK)-3β activation and cyclin D1 suppression [PMID:25704018]. It also demonstrates anti-proliferative and vasorelaxant properties in pulmonary artery smooth muscle cells [PMID:32188043].
Bailing capsules (derived from C. sinensis) significantly improved forced expiratory volume in 1s (FEV1), FEV1/FVC ratio, and 6-min walk test (6MWT) results [PMID:39460586].
Preuve BChronic Bronchitis (CB)
Bailing capsule significantly reduced the frequency of acute exacerbation of CB compared with placebo [PMID:39193337].
Preuve AHemodialysis
Adjunctive use of cordyceps or fermented products significantly improved C-reactive protein levels [PMID:32186018].
Preuve AChronic Kidney Disease (CKD)
Used as a common ingredient for treatment, though a systematic review aimed to evaluate therapeutic and adverse effects [PMID:25519252].
Preuve AKidney Transplant
Evaluated as an adjuvant immunosuppressive agent to assess graft rejection and survival rates [PMID:28137532].
Sécurité et effets indésirables
C. sinensis is suggested to have minimal side effects [PMID:39331691]. One study on Bailing capsules for chronic bronchitis assessed safety alongside efficacy [PMID:39193337].
Synthèse des preuves
Evidence ranges from high-level meta-analyses for respiratory and renal adjunctive therapies to review-level data on biochemical constituents and animal/in-vitro models for inflammation and cancer.
Sources PubMed
1.PMID: 24716152 (2013) — A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients. · Journal of traditional and complementary medicine
2.PMID: 29371523 (2017) — Entomopathogenicity and Biological Attributes of Himalayan Treasured Fungus Ophiocordyceps sinensis (Yarsagumba). · Journal of fungi (Basel, Switzerland)
3.PMID: 39519748 (2024) — Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. · Molecules (Basel, Switzerland)
4.PMID: 32288794 (2013) — Properties of Cordyceps Sinensis: A review. · Journal of functional foods
5.PMID: 38048742 (2024) — An authentic assessment method for cordyceps sinensis. · Journal of pharmaceutical and biomedical analysis
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
6.PMID: 28716290 (2017) — Yarsagumba Fungus: Health Problems in the Himalayan Gold Rush. · Wilderness & environmental medicine
7.PMID: 25519252 (2014) — Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. · The Cochrane database of systematic reviews
8.PMID: 35645822 (2022) — Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review. · Frontiers in pharmacology
9.PMID: 39460586 (2024) — Therapeutic efficacy and pharmacological mechanism of Bailing capsule on chronic obstructive pulmonary disease: a meta-analysis and network pharmacology. · Pharmaceutical biology
10.PMID: 23688494 (2014) — Advanced development in chemical analysis of Cordyceps. · Journal of pharmaceutical and biomedical analysis
11.PMID: 24266368 (2013) — The artificial cultivation of medicinal Caterpillar Fungus, Ophiocordyceps sinensis (Ascomycetes): a review. · International journal of medicinal mushrooms
12.PMID: 39193337 (2024) — Efficacy and safety of Cordyceps sinensis (Hirsutella sinensis, Cs-C-Q80) in chronic bronchitis. · Frontiers in pharmacology
13.PMID: 32305637 (2020) — Can Cordyceps cicadae be used as an alternative to Cordyceps militaris and Cordyceps sinensis? - A review. · Journal of ethnopharmacology
14.PMID: 39331691 (2025) — Ethnopharmacology and current conservational status of Cordyceps sinensis. · Zeitschrift fur Naturforschung. C, Journal of biosciences
15.PMID: 27874103 (2016) — Cordyceps collected from Bhutan, an appropriate alternative of Cordyceps sinensis. · Scientific reports
16.PMID: 40125085 (2025) — Cordyceps Sinensis Reduces Inflammation and Protects BEAS-2B Cells From LPS-Induced THP-1 Cell Injury. · Journal of inflammation research
17.PMID: 32362940 (2014) — Recent advances in Cordyceps sinensis polysaccharides: Mycelial fermentation, isolation, structure, and bioactivities: A review. · Journal of functional foods
18.PMID: 25960753 (2015) — The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis. · Evidence-based complementary and alternative medicine : eCAM
20.PMID: 36443322 (2022) — Cordyceps cicadae and Cordyceps gunnii have closer species correlation with Cordyceps sinensis: from the perspective of metabonomic and MaxEnt models. · Scientific reports
21.PMID: 25704018 (2015) — Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. · Journal of pharmacological sciences
22.PMID: 28911537 (2017) — Functional study of Cordyceps sinensis and cordycepin in male reproduction: A review. · Journal of food and drug analysis
23.PMID: 30394122 (2019) — A breakthrough in the artificial cultivation of Chinese cordyceps on a large-scale and its impact on science, the economy, and industry. · Critical reviews in biotechnology
24.PMID: 40706428 (2025) — Integrating proteomics, metabolomics, and network pharmacology to investigate the mechanism of Cordyceps sinensis in the treatment of COPD rats. · Journal of pharmaceutical and biomedical analysis
25.PMID: 32188043 (2020) — Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties. · Medicina (Kaunas, Lithuania)
26.PMID: 28137532 (2017) — Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: A systematic-review and meta-analysis. · Complementary therapies in medicine
27.PMID: 37440993 (2023) — Research Progress of Cordyceps sinensis and Its Fermented Mycelium Products on Ameliorating Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition. · Journal of inflammation research
28.PMID: 40001886 (2025) — Comparative Metabolite Profiling Between Cordyceps sinensis and Other Cordyceps by Untargeted UHPLC-MS/MS. · Biology
29.PMID: 38375041 (2024) — Chemical components in cultivated Cordyceps sinensis and their effects on fibrosis. · Chinese herbal medicines
30.PMID: 32186018 (2019) — Efficacy of Cordyceps sinensis as an adjunctive treatment in hemodialysis patients: a systematic review and Meta-analysis. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan